 Nov 1 2022
Recent article published in Molecular Oncology with MedRod® implants i...
|
 |
| PRICE QUOTE AND TECHNICAL INQUIRIES |
FOLLOW US
 |
|
|
Nov 1 2022
Recent article published in Molecular Oncology with MedRod® implants in the Orthotopic in vivo xenografts! Molecular Oncology
July 1 2022
Preclinapps has started developing Letrozole implant for sustained release for research purposes. We plan to finalize the development work during early Autumn.
June 4 2021
Preclinapps is carrying out a research program to investigate 3D printing of drug delivery implants. 3D printing by extrusion technology utilizing biopolymers enables various novel applications for MedRod® implants.
September 25, 2020,
We have great pipeline of new products under development. Upon big demand we have developed slow release implants for Prednisone and Progesterone for the research use. Implants fulfill the same high-quality specs as all the other implants manufactured by Preclinapps meaning true controlled and stable release rates. Let us know if you have such research needs in preclinical drug discovery field!
November 8, 2019,
Preclinapps attends BioFIT 2019 conference in Marseille, France on 10-11 December 2019. See you there!
April 14, 2019,
Meet us at the IABCR breast cancer conference 15-18 April, Egmond aan Zee, The Netherlands.
April 1, 2019
Attending Health 19 & SkiLiftPitch event at Tahko Finland 4-5 April 2019. Business, networking and skiing!
January 18, 2019
See our references page to find list of selected publications and presentations demonstrating performance of the MedRod dosing technology.
October 8, 2018
Meet us at the EACR-AACR-ISCR Conference: The Cutting Edge of Contemporary Cancer Research, 9-11 October, Jerusalem, Israel. Our MedRod dosing technology for in vivo research use allow adjustable sustained drug release from weeks to several months, even up to years. Drug compounds can be supportive compounds for research model, such as hormones or Your novel drug compound. If you want to hear more, please contact us at info(a)preclinapps.com
April 27, 2018
Our MedRod products have been widely used in various preclinical studies. Pharmatest Services Ltd, a contract research organization, is presenting latest validation data of LNCaP prostate cancer model with DHT-MedRod data included at the Scand-LAS annual meeting 2018, 26-28 April, Kristiansand, Norway
The poster outlines the importance of correct doses of supplemental hormones in preclinical cancer models. Please ask more information at info(a)preclinapps.com
March 2, 2018
We have developed novel extremely low and stable daily release implants for estrogenic hormones to be used in preclinical studies. For estrone, even 10 nanogram stable daily release can be achieved. Nanogram level stable release cannot be achieved by any other competing solutions. The release has been validated by dissolution studies for 100 hundred days, but theoretically it is stable for several years. Please ask more information at info(a)preclinapps.com
November 27, 2017
EACR cancer meeting, 27-29 November 2017, Berlin, Germany
November 9, 2017
Meet us at the World Preclinical Congress Europe, 15-17 November 2017, Lisbon, Portugal. Come and see our scientific presentation or book a meeting with us by contacting at info(a)preclinapps.com
May 30, 2017
Meet PreclinApps at the 47th Annual Scand-LAS 2017 Meeting in Copenhagen, May 30 - June 2, 2017.
http://www.scandlas2017.dk/index.html
If you want to book a meeting with us during the meeting, please contact us: info(at)preclinapps.com
March 29, 2017
We are pleased to see that our MedRod products have been widely used in various preclinical studies. Pharmatest Services Ltd, a contract research organization, is giving oral presentation with MedRod data included at the Annual Meeting of AACR (Washington, D.C., USA), the leading scientific event in the field of cancer research. If you are attending the meeting, join the session “Novel Approaches for Experimental Therapeutics" on Tuesday April 4 at 4.05 - 4.20 pm Room 144, level 1.
For more information: http://www.pharmatest.com/index.php/news/pharmatest-attends-aacr-annual-meeting-washington/
If you want to book a meeting with us during the meeting, please contact us: info(at)preclinapps.com
November 8, 2016
Meet PreclinApps at World Preclinical Congress Europe, 14-16 November 2016, Lisbon, Portugal. If you would like to meet us, please contact us at info(a)preclinapps.com
August 12, 2016
PreclinApps Ltd attends Nordic Life Science Days 2016 conference in Stockholm, Sweden on September 14 - 15, 2016. If you would like to meet with our representative in Stockholm, please contact us at info(a)preclinapps.com or via the conference official partnering sites.
June 8, 2016
PreclinApps Ltd attends Annual Meeting of the Federation of Laboratory Animal Science Associations (FELASA) that will be held in Brussels, Belgium on June 13 - 16, 2016. PreclinApps welcomes everyone to visit our booth #A004
Visit website: FELASA 2016
March 30, 2016
PreclinApps Ltd attends Annual Meeting of Experimental Biology (EB 2016) that will be held in San Diego, CA, USA on April 2 - 6, 2016. PreclinApps welcomes everyone to visit our booth #1721 and our scientific posters during poster sessions. More information about the meeting from the official website: Experimental Biology 2016
May 8, 2015
Welcome to our booth at Scand-LAS Annual Meeting (9-12 June) in Turku, Finland.
January 28, 2015
PreclinApps present at animal welfare seminar in Oulu.
Launch of product marketing!
November 5, 2014
The new products will be presented for the first time in the various scientific meetings throughout 2015. The meetings will be announced soon.
October 31, 2014
Preclinapps is proud to inform development of new long term drug delivery systems called medicated rods for preclinical research that will be soon available as commercial products.
|  | |
|
